SCHEMBL7045330

SCHEMBL7045330

O=C(Cl)CCCF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18528138 0.91
SCHEMBL21295304 0.88 ALDH1A1 (0.56)
SCHEMBL8417525 0.88
SCHEMBL6924030 0.88 ALDH1A1 (0.56)
SCHEMBL3082520 0.80
SCHEMBL132364 0.79 TSHR (0.67)
SCHEMBL180666 0.79
SCHEMBL496221 0.76 TSHR (0.72)
SCHEMBL466419 0.76 TSHR (0.72)
SCHEMBL2154814 0.76 TSHR (0.72)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116041669-A Epoxy resin monomer and preparation method and application thereof 中国建筑材料科学研究总院有限公司 2023-05-02 CN disclosed
EP-3109230-B1 CLASS OF CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN PREPARATION OF PRODRUGS LI QINGENG (CN) 2019-11-20 EP disclosed
EP-3109229-B1 WATER-SOLUBLE PROPOFOL DERIVATIVES AND USES THEREOF JIANGSU NHWALUOKANG PHARMACEUTICAL RES AND DEVELOPMENT CO LTD (CN) 2019-06-05 EP disclosed
US-10239851-B2 Carboxylic acid derivatives and use thereof in the preparation of prodrugs Li, Qingeng (CN) 2019-03-26 US disclosed
US-9643917-B2 Water-soluble propofol derivatives and uses thereof JIANGSU NHWALUOKANG PHARMCEUTICAL RESEARCH AND DEVELOPMENT CO., LTD (CN) 2017-05-09 US disclosed
US-20170057939-A1 CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN THE PREPARATION OF PRODRUGS LI, Qingeng (CN) 2017-03-02 US disclosed
US-9580444-B2 Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2017-02-28 US disclosed
US-20170050920-A1 WATER-SOLUBLE PROPOFOL DERIVATIVES AND USES THEREOF JIANGSU NHWALUOKANG PHARMCEUTICAL RESEARCH AND DEVELOPMENT CO., LTD (CN) 2017-02-23 US disclosed
EP-3109230-A1 CLASS OF CARBOXYLIC ACID DERIVATIVES AND USE THEREOF IN PREPARATION OF PRODRUGS Li, Qingeng (CN) 2016-12-28 EP disclosed
EP-3109229-A1 WATER-SOLUBLE PROPOFOL DERIVATIVES AND USES THEREOF Jiangsu Nhwaluokang Pharmceutical Research and Development Co. Ltd. (CN) 2016-12-28 EP disclosed
CN-103145715-A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication HOFFMANN LA ROCHE 2013-06-12 CN disclosed
CN-102020697-A Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication INTERMUNE INC 2011-04-20 CN disclosed
CN-1938311-A Macrocyclic compounds as inhibitors of viral replication INTERMUNE INC (US) 2007-03-28 CN disclosed
CN-1229382-C Semi-synthetic process and intermediates thereof PHARMA MAR SA (ES) 2005-11-30 CN disclosed
EP-1392779-A1 FLUORINATED-PHOTOINITIATORS IN DUAL CURE RESINS Ciba SC Holding AG (CH) 2004-03-03 EP disclosed
CN-1360588-A Hemisynthetic method and intermediate thereof PHARMA MAR SA (ES) 2002-07-24 CN disclosed
WO-2002040602-A1 FLUORINATED-PHOTOINITIATORS IN DUAL CURE RESINS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-05-23 WO disclosed
US-5672701-A 4-substituted alkyl carbapenem antibiotics BRISTOL-MYERS SQUIBB COMPANY (US) 1997-09-30 US disclosed
CN-1030918-C 4-substituted alkyl carbapenem antibiotics BRISTOL MYERS SQUIBB CO (US) 1996-02-07 CN disclosed
EP-0433759-A1 4-Substituted alkyl carbapenem antibiotics Bristol-Myers Squibb Company (US) 1991-06-26 EP disclosed